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Abstract
Background: Recent reports suggest that Natural Killer (NK) cells may modulate pathogenesis of primary HIV-1 infection.
However, HIV dysregulates NK-cell responses. We dissected this bi-directional relationship to understand how HIV impacts
NK-cell responses during primary HIV-1 infection.
Methodology/Principal Findings: Paired samples from 41 high-risk, initially HIV-uninfected CAPRISA004 participants were
analysed prior to HIV acquisition, and during viraemic primary HIV-1 infection. At the time of sampling post-infection five
women were seronegative, 11 women were serodiscordant, and 25 women were seropositive by HIV-1 rapid immunoassay.
Flow cytometry was used to measure NK and T-cell activation, NK-cell receptor expression, cytotoxic and cytokine-secretory
functions, and trafficking marker expression (CCR7, a4b7). Non-parametric statistical tests were used. Both NK cells and T-
cells were significantly activated following HIV acquisition (p = 0.03 and p,0.0001, respectively), but correlation between
NK-cell and T-cell activation was uncoupled following infection (pre-infection r = 0.68;p,0.0001; post-infection, during
primary infection r = 0.074;p = 0.09). Nonetheless, during primary infection NK-cell and T-cell activation correlated with HIV
viral load (r = 0.32’p = 0.04 and r = 0.35;p = 0.02, respectively). The frequency of Killer Immunoglobulin-like Receptor-
expressing (KIRpos) NK cells increased following HIV acquisition (p = 0.006), and KIRpos NK cells were less activated than
KIRneg NK cells amongst individuals sampled while seronegative or serodiscordant (p = 0.001;p,0.0001 respectively). During
HIV-1 infection, cytotoxic NK cell responses evaluated after IL-2 stimulation alone, or after co-culture with 721 cells, were
impaired (p = 0.006 and p= 0.002, respectively). However, NK-cell IFN-y secretory function was not significantly altered. The
frequency of CCR7+ NK cells was elevated during primary infection, particularly at early time-points (p,0.0001).
Conclusions/Significance: Analyses of immune cells before and after HIV infection revealed an increase in both NK-cell
activation and KIR expression, but reduced cytotoxicity during acute infection. The increase in frequency of NK cells able to
traffic to lymph nodes following HIV infection suggests that these cells may play a role in events in secondary lymphoid
tissue.
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Introduction
Understanding immunological responses that modulate HIV-1
pathogenesis is important for vaccine and immunotherapy
development. Events that occur during the earliest period of
HIV-1 infection disproportionately influence the outcome and
course of disease. In particular, generalized activation of CD8 T-
cells is associated with faster disease progression [1], whilst HIV-
specific CD8+ and CD4+ T-cell responses during primary
infection are associated with slower disease progression and
lower set point viral load [2,3,4]. Although the effects of HIV-1
infection on adaptive immune cells, particularly T-cells have
been well described, the impact on innate immune responses are
less well understood. Natural Killer (NK) cells, are part of the
innate immune defense against viral infections and modulate
subsequent adaptive immune responses [5]. In vitro and animal
studies suggest a possible role of NK cells in controlling viral
replication during primary HIV-1 infection [6]. NK cells can
limit HIV replication through direct killing of infected cells as
well as the secretion of anti-viral cytokines. However, HIV can
also impair immune responses by NK cells [7,8,9]. By examining
the responses of NK cells prior to infection and at the earliest
time points following infection, we may better unravel cause-
effect relationships of HIV impact on immune responses and
vice-versa.
During chronic HIV-1 infection NK-cell cytotoxicity and cytokine
secretion are impaired, but these deficiencies likely start earlier in the
course of disease [10]. The impairments are associated with
expansion of an ‘‘anergic’’ NK cell subset that expresses CD16
and relatively low levels of CD56 (CD56negCD16pos). Some
investigators have also proposed that this subset functionally impairs
the total NK cell population [11]. In vitro models of HIV infection
suggest that HIV viraemia contributes to this impairment [9].
Viraemia peaks early following acquisition, during primary HIV
infection. Thus, NK cell dysregulation in vivo likely begins during
primary infection. This hypothesis is supported by the findings of
Alter and colleagues [7]. In a study of 10 acutely infected individuals,
they reported quantitative expansion of NK cell populations during
the seronegative phase of primary HIV-1 infection that rapidly
returned to baseline, but remained qualitatively different from 14
healthy HIV-uninfected individuals, or 45 individuals with chronic
HIV. They observed NK cell expansion prior to the development of
adaptive (CD8+ T-cell) responses. They also found that NK-cell
degranulation and interferon-gamma (IFN-c) secretion were elevat-
ed in the seronegative phase of infection but declined subsequently
independent of antiretroviral treatment status. However the lack of
blood samples from the same individuals prior to HIV acquisition
limited the conclusions from this study [12].
Few studies have quantified immune responses before and after
HIV infection among the same individuals. Most previous studies
compare immune responses in HIV acutely infected individuals to
uninfected individuals [13]. Here we extend the findings of
previous studies by characterizing innate immune responses in the
same individuals before and after HIV acquisition. To better
understand the kinetics of NK-cell responses in primary HIV-1
infection we compared innate immune responses in paired blood
specimens collected prior to and during primary infection among
women who acquired HIV whilst enrolled in a randomized,
controlled clinical trial of 1% Tenofovir microbicide gel. Our
findings provide new insights into the effects of HIV on NK-cell
responses.
Methods
Study Subjects
This prospective cohort study was nested in the CAPRISA 004
Tenofovir gel trial of coitally-related use of 1% Tenofovir gel [14].
The trial enrolled 889 sexually active (defined as .2 sex acts in
preceding 30 days) women 18–40 years of age, who were resident
in high-prevalence rural and urban communities. For this study,
41 consenting adult women, who acquired HIV whilst in the trial,
were selected based on sample availability. Incident HIV infection
was established by two rapid HIV antibody tests and confirmed by
negative qualitative HIV PCR testing of pre-infection samples. In
cases of diagnostic uncertainty, Western blots and/or an HIV-1
ELISA were performed. To characterize changes in NK cells in
women who acquired HIV-1, and whether these were associated
with changes in T-cell activation or function, we examined NK
cell and T-cell responses at the last sampling time point before
infection and during primary HIV-1 infection.
Participants gave informed consent for their samples to be
stored and used for this study. This study was approved by the
University of KwaZulu-Natal Biomedical Research Ethics Com-
mittee (#BE073/010). The clinical trials registration number of
parent trial was NCT00441298.
Natural Killer cell and T-cell activation
Activation, CD107a expression and intracellular cytokine
production were measured in cryopreserved peripheral blood
mononuclear cells (PBMC) in batch analyses using optimized flow
cytometry methods as previously described [15]. Cryopreserved
PBMC were rapidly thawed in warm media (RPMI 1640; Gibco),
washed and rested for two hours. Sample viability and cell counts
were determined by staining with Viacount (Millipore) and run on
a Guava PCA (Millipore). PBMC were stained with Yellow
Viability Dye (Invitrogen), anti-CD14 (clone Tuk4, Invitrogen)
and -CD20 (clone HI47, Invitrogen) antibodies (to exclude
nonviable cells, monocytes and B-cells, respectively). In addition,
the cells were stained with anti-CD3 (clone SP34-2, BD
Biosciences),-CD16 (clone 3G8, BD Biosciences),-CD38 (clone
HIT2, BD Biosciences),-CD56 (clone B159, BD Biosciences),-
CD69 (clone FN50, BD Biosciences),-CD158a (cone HP-3E4, BD
Biosciences),-CD158b (clone CH-L, BD Biosciences), -HLA-DR
(clone L243, BD Biosciences) and anti-CD158e1/e2 (clone Z27,
Beckman Coulter) antibodies. Flow cytometry data were collected
on a BD LSRII and analyzed using FlowJo v9.3.1 (Treestar). NK
cells were defined as viable, CD14neg, CD20neg, CD3neg, CD16/
56pos lymphocytes. The frequency of NK cells that were HLA-
DRpos was determined using fluorescence minus one (FMO) gates.
The frequency of T-cells, defined as viable, CD14neg, CD20neg
CD3pos cells, expressing both CD38 and HLA-DR, was similarly
determined. The gating strategy is shown in Figure S1.
NK-cell effector functions
Using cryopreserved PBMCs in batched analyses each of the
following three NK-cell effector functions were quantified
following IL-2 stimulation (100 U/ml R+D Systems) alone, IL-2
plus 721 cells or PMA/Ionomycin: degranulation (using CD107a
expression as a surrogate [16]), cytokine secretion (IFN-c), and
recent cell division (using Ki-67 as a surrogate [17]). Cryopre-
served PBMC were rapidly thawed in warm media, washed and
rested for 12 hours in IL-2 enriched culture medium (RPMI 1640
media containing 50 U/ml IL-2 and 10% fetal calf serum). For
experiments in which cells were stimulated with 721 cells, the NK
cells were cultured with equal numbers of 721 cells. Cells were
washed, resuspended in culture medium containing an antibody
Natural Killer Cells in Primary HIV-1
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directed against CD107a, and cultured for a further 6 hours.
Samples were processed for flow cytometry as detailed above with
the following modification. Cells were surface stained with anti-
CD3 (clone SP34-2, BD Biosciences), -CD8 (clone 3B5, Invitro-
gen), -CD56 (clone B159, BD Biosciences), -CD69 (clone FN50,
BD Biosciences) and anti-CD7 (clone 8H8.2, Beckman Coulter)
antibodies, then washed, fixed and permeabilised before staining
with anti-Ki-67 (clone B56, BD Biosciences) and -IFN-c (clone
4S.B3, BD Biosciences) antibodies, respectively. To account for
NK cells that have lost CD16 expression due to activation and to
exclude monocyte/DC-like cells, anti-CD7 antibody was used as
described [18]. FMO gates were used to determine the proportion
of cells responding with one or more effector functions (i.e.,
CD107a, IFN-c or Ki-67). The gating strategy is shown in Figure
S2.
Statistical methods
Assays were conducted blinded to time point of sampling. For
comparisons between paired specimens at pre- and post-infection
time points from the same individual, a non-parametric Wilcoxon
signed rank test was performed. For comparisons between
different time points post-infection, a Kruskal-Wallis test was
performed. Statistical analyses were conducted in GraphPad Prism
v5 (GraphPad).
Results
To characterize the earliest changes in innate and adaptive
immune responses induced by HIV-1, we examined NK-cell and
T-cell responses, respectively, prior to HIV acquisition and during
primary infection. Unlike most prior studies these responses were
measured in the same individuals over time.
Study cohort
A total of 41 recently infected women were included in this
study, (mean age 23.3 years). Thirty-one were in the tenofovir arm
and eight in the placebo arm. To take into account differences
between post-infection sampling time points in this cohort, the
results were stratified by stage of HIV-1 infection at the time of
sample collection. Blood samples collected at the last visit prior to
HIV acquisition (hereafter referred to as pre-infection) were
collected at a median of 119 days prior to HIV acquisition, IQR
67.25–169.25). The samples collected from these women at the
first visit following HIV infection were designated as post-infection
samples. HIV serostatus (seronegative versus seropositive) of the
samples was only used in reference to samples collected after HIV
acquisition (i.e., post-infection). Five participants were sampled
during the seronegative stage of primary infection based on two
HIV rapid tests (seronegative group), 11 whilst having indeterminate
or discordant antibody responses (discordant group) and 25 during
the seropositive stage of infection (seropositive group). Due to
limited cell numbers, we were unable to assess NK-cell degran-
ulation, proliferation or cytokine secretion in two seronegative, two
discordant, and three seropositive individuals.
Based on estimates of the date of infection confirmed by BEAST
analysis of viral sequences, seronegative, discordant and seropos-
itive individuals were sampled at a median (IQR) of 14 (13.5–14),
15 (13–25) and 131 (105.5–157) days post-infection respectively.
The median viral load (log10 copies/ml) (IQR) was 4.95 (4.39–
5.29), 4.63 (4.19–5.34) and 3.86 (3.38–4.80) for seronegative,
discordant and seropositive groups respectively. The correspond-
ing probable Fiebig staging was based on a combination of the
estimated time post-infection at sampling and ancillary HIV PCR,
Western blot and/or ELISA results, where available, were I/II/
early III; III/IV, and V/VI for seronegative, discordant and
seropositive groups, respectively.
Consistent with a previous report on this cohort by Mureithi et
al. [19] we did not observe any significant differences in any of the
measured parameters between women who acquire HIV whilst
receiving 1% Tenofovir gel compared with women on placebo gel.
For this reason the groups were combined in further analyses.
NK-cell and T-cell activation were uncoupled by primary
HIV-1 infection, but both were positively correlated with
HIV viral load
The proportions of activated T-cells and NK cells were
significantly increased during primary HIV-1 infection
(p,0.0001 and p= 0.03, Figures 1A and 1B, respectively). Prior
to HIV acquisition, the proportions of activated NK cells and T-
cells were positively correlated (r = 0.68, p,0.0001, Figure 1C),
whereas following infection, they were uncoupled (r = 0.074,
p = 0.09, Figure 1D). Nevertheless, the proportions of activated
T-cells and NK cells correlated independently with HIV viral load
(r = 0.32, p = 0.04 and r = 0.35, p= 0.02, respectively; Figures 1E
and 1F) but not with CD4+ T-cell counts (Figure 1G and H).
As a proportion of lymphocytes, NK cells were not significantly
expanded during primary infection (Figure S3A). To take into
account differences between post-infection sampling time points in
this cohort the results were stratified by stage of HIV-1 infection
when samples were collected. We observed no significant
difference in frequencies of NK cells during primary infection
between seronegative, serodiscordant and seropositive individuals
(p = 0.41; Figure S3B) although a weak trend to greater
frequencies in seronegative individuals was present. Similarly,
there was no difference in the frequencies of recently divided NK
cells as measured by expression of Ki-67 (Figure S3C and 3D).
Although the difference in proportions of activated NK cells was
not statistically significant, there was a tendency for greater
activation during later stages of primary infection (Figure S3E).
The frequencies of the CD56neg (anergic), CD56dim and CD56
hi
NK cell subsets did not differ between pre-infection and post-
infection time points, nor amongst the stages of primary infection
(Figure S4A and 4B). In contrast, the proportion of recently
divided CD8+ T-cells increased following HIV-1 infection
(p,0.0001, Figure S5A).
The frequency of Killer Immunoglobulin-like Receptor
expressing NK cells (KIRpos) increased following HIV-1
infection with KIRpos NK cells being less activated than
KIRneg NK cells
Next, to explore whether KIRs contributed to the observed
changes in activation profiles of NK cells, KIR expression was
evaluated by flow cytometry. For this analysis commercial
antibodies, which detected the most commonly expressed KIRs
(KIR2DL1, KIR2DS1, KIR2DL2, KIR2DL3, KIR3DL1 and
KIR3DS1), were used. A significant expansion in the proportion
of KIRpos NK cells was evident following HIV-1 infection
(p = 0.006, Figure 2A) and appeared higher in individuals with
seronegative primary HIV-1 infection but this was not significant
(Figure 2B). Since KIR modulate NK cell activation, activation on
KIRpos and KIRneg cells was compared in each category of
samples. Prior to HIV infection, the proportion of KIRpos NK cells
that were activated was significantly lower than KIRneg NK cells
(p,0.0001, Figure 2C). During primary HIV-1 infection, KIRpos
NK cells were similarly less activated than KIRneg NK cells
amongst those with discordant or seropositive primary HIV-1
infection (p= 0.001, p,0.0001 respectively, Figure 2C). This did
Natural Killer Cells in Primary HIV-1
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not achieve statistical significance in the smaller group with
seronegative primary HIV-1 infection (p= 0.13, Figure 2C).
NK cell function was impaired during primary HIV-1
infection
To quantify the effects of HIV on NK-cell function, we assessed
NK cell degranulation and interferon-gamma (IFN-c) secretion in
paired blood samples collected prior to HIV acquisition and after
infection, during the early stages of primary infection. The samples
were analyzed after ex vivo culture in media containing Interleukin-
2 (IL-2) alone, or after exposure to 721 cells (a B-cell line deficient
in HLA class 1 expression) and IL-2, or PMA/Ionomycin and IL-
2. For this assay NK cells were defined as CD3neg cells expressing
CD7, as done previously by Milush and colleagues [18].
Following ex vivo culture in media containing IL-2 stimulation
alone, the proportion of degranulating NK cells was elevated
Figure 1. Primary HIV-1 infection was associated with differential T-cell and NK-cell activation. T-cells (A) and NK cells (B) were activated
following HIV infection. The proportion of activated T-cells and NK cells was significantly correlated before (C), but not following HIV-1 infection (D). In
contrast, during primary infection, both T-cell (E) and NK-cell (F) activation were positively correlated with HIV viral load (log10 copies/ml) but not
CD4+ T-cell counts (G and H respectively).
doi:10.1371/journal.pone.0053251.g001
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PLOS ONE | www.plosone.org 4 January 2013 | Volume 8 | Issue 1 | e53251
during primary HIV-1 infection compared to prior to HIV
acquisition, (p = 0.006, Figure 3A). In contrast, the degranulation
response of NK cells to 721 cells, (a model of ‘‘missing self’’) [20],
was significantly reduced during primary HIV-1 infection
(p = 0.002, Figure 3A). Similarly, stimulation by PMA/Ionomycin
showed the same tendency, but this difference did not reach
statistical significance (p = 0.06, Figure 3A). There was no
difference in the proportion of NK cells secreting IFN-c following
ex vivo IL-2 stimulation alone (Figure 3B). Following stimulation
with 721 cells there was a tendency of fewer NK cells secreting
IFN-c after HIV acquisition (p = 0.09, Figure 3B). Likewise, the
proportion of NK cells secreting IFN-c following stimulation with
PMA/Ionomycin was significantly lower after infection (p = 0.03).
In contrast to NK cells, the proportion of degranulating CD8+ T
was increased following HIV-1 infection (p= 0.02, Figure S5B)
and there was no change in the proportion of IFN- cpos CD8+ T-
cells (Figure S5C).
The frequency of NK cells expressing markers for homing
to lymphoid tissues is increased during primary HIV-1
infection
Finally, to measure the impact of HIV acquisition on NK cell
trafficking we quantified the expression of receptors for lymphoid
and gastrointestinal tissue homing. We quantified the frequency of
NK cells expressing either CCR7, which enables trafficking to
lymphoid tissues [21], or a4 and b7 integrins, which enable
homing to the gut [22]. After infection the frequency of CCR7+
cells increased markedly (p =,0.0001, Figure 4A). The propor-
tion of CCR7+ NK cells was decreased with later category of
primary HIV-1 infection but did not return to baseline (p,0.0001,
Figure 4A). In contrast, the proportion of NK cells expressing both
the a4 and b7 integrin subunits remained unchanged (Figure 4B).
Discussion
Primary HIV-1 infection is associated with differential NK cell
and T-cell activation, expansion of NK cells expressing KIR,
impairment of cytotoxic NK cell function in the absence of
significant increase in anergic subsets, and NK cells equipped to
home to secondary lymphoid tissues. These data offer insight into
the impact of primary HIV-1 infection on NK cells.
Unlike prior studies that cross-sectionally analysed acutely
infected and uninfected individuals [7,12], this study was unique in
following immune responses over-time before and after HIV
acquisition. The relatively small sample size of samples collected
during the seronegative phase of infection limited our ability to
compare responses during the seonegative versus seropositive
stages of acute infection. Nevertheless, our finding that both NK
cells and T-cells were activated early following HIV infection was
consistent with previous findings by Alter and colleagues [12].
However, during primary infection we did not observe a
significant expansion in the frequency of NK cells amongst total
lymphocytes that has been described previously [12]. Alter and
colleagues noted an expansion of NK cells among HIV-infected,
seronegative individuals compared to uninfected individuals. Since
most of the post-infection samples used in this study were collected
during the seropositive phase of primary infection, we speculate
Figure 2. Following infection, an increased proportion of activated NK cells in blood expressed Killer Immunoglobulin-like
Receptors (KIR). The proportion of KIRpos NK cells in blood increased following HIV infection (A). The proportion of KIRpos NK cells did not differ
between stages of primary HIV infection (seronegative, sero-discordant or seropositive stages) (B). KIRpos NK cells were more activated than KIRneg NK
cells (C).
doi:10.1371/journal.pone.0053251.g002
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that NK-cell expansion may have occurred prior to our sampling
time points. In addition, the relatively low number of seronegative
individuals limited our statistical power to detect these differences.
Therefore, our results are consistent with other reports that suggest
that NK cell population expansion occurs early in primary
infection but may be transient [7,12].
In this study NK cell and T-cell activation were uncoupled by
primary HIV-1 infection illustrating the differential effects of HIV
on NK cells and T-cells. This finding appears to be mostly
explained by the relatively greater increase in T-cell activation.
Alter and colleagues have previously shown that T-cell responses
occur after NK-cell responses and are inversely correlated with the
magnitude of NK cell activity during primary infection [23].
Primary HIV-1 infection was associated with expansion of KIRpos
NK cells, consistent with a previous study, but was not associated
with enhanced KIRneg NK cell activation. We speculate that this
may be due to either expansion of NK cells able to detect HIV-1-
infected cells that down-regulate HLA expression, or a regulatory
response that diminishes NK cell reactivity. Fogli and colleagues
have previously demonstrated that KIRpos NK cells are incom-
pletely activated in individuals with chronic HIV infection [8],
which implies that this may be a regulatory mechanism. In this
study we were not able to delineate which specific KIR (inhibitory
versus activating) were expressed on the surface of NK cells.
Further studies using newer reagents that can distinguish specific
KIR are needed to understand the regulation of KIR expression in
NK cells during primary infection.
Consistent with previous studies, NK cell function following
stimulation with 721 cells or PMA/Ionomycin was impaired as
early as primary HIV-1 infection even in the absence of significant
expansion of anergic NK cells (CD56negCD16pos) [7]. After
infection, a higher proportion of NK cells degranulated in the
presence of only IL-2 than before infection. This suggests that HIV
may prime responses or that NK cells are degranulating in vivo in
response to HIV. However, their response to culture with 721 cells
was diminished. Similarly, their responses to non-specific stimu-
lation with PMA/Ionomycin were reduced. These results suggest
that NK cell functional deficiencies during primary infection might
be attributed to impaired or incomplete activation rather than the
accumulation of anergic NK cells.
Finally, we observed an increase in the frequency of blood NK
cells expressing CCR7, a receptor for homing to lymphoid tissues.
We did not observe a similar expansion of NK cells expressing
a4b7 integrins for homing to the gut. In contrast to our findings,
Luteijn and colleagues did not observe a higher frequency of
CCR7+ NK cells in blood from HIV-infected compared to
uninfected individuals in their cross-sectional analysis [24]. One
difference between these studies is that the participants in the study
by Luteijn et al. were beyond the acute phase, but within the first
year of HIV infection. Thus, the changes in CCR7 expression that
we observed may be transient and limited to the acute phase of
infection. In a previous study we found that chemokine receptor
expression on NK cells changes rapidly [15]. In addition, the wide
variation between individuals in the magnitude of change may also
explain differences in the outcomes. In this study we noted a
relatively large increase in the proportion of CCR7+ NK cells
among some individuals and a much more subtle increase among
others. Longitudinal assessment of changes in the frequency of
CCR7+ NK cells within individuals would take some of this
variability into account, and thus enable the detection of
differences not apparent in a cross-sectional analysis. We propose
that the increase in the frequency of KIRpos NK cells in blood may
also increase the proportion of NK cells that are able to traffic to
lymphoid tissues. In support of this model, Marcenaro and
colleagues previously showed that KIR-ligand mismatch was
required for the ex vivo up-regulation of CCR7 expression by
human NK cells interacting with either monocyte-derived
dendritic cells or Epstein Barr Virus (EBV)-transformed B-cell
lines [25]. It has been well-described that HIV decreases the
expression of selected HLAs, which are ligands for KIRs [26].
Based on these observations, we speculate that the expansion of
KIR-expressing NK cells concurrent with relative reduction in
HLA-ligand expression simulates KIR-ligand mismatch and may
facilitate NK cell CCR7 up-regulation and homing to lymphoid
tissues. But Luteijin and colleagues observed relatively few KIRpos
NK cells in the lymph nodes of HIV-infected individuals [24]
suggesting that these events may be transitory. Additional studies
are need to determine if changes in NK-cell compartmentalization
occur in vivo and whether it influences the viral load set point in the
acute phase of HIV infection. Studies may also need to track NK
cell homing longitudinally in order to determine whether, for
example, the observation of lack of a4b7pos NK cell expansion is
because NK cells home to the gut earlier than we were able to
observe.
Several factors limit our conclusions. Firstly, we previously
found that women in this cohort, who acquired HIV-1, had higher
activation and lower NK cell responses prior to infection than
women who remained uninfected [27,28]. Hence, these results
may be generalizable to South African women who subsequently
acquire HIV heterosexually, but they may not be generalizable to
other populations. Future studies should consider whether pre-
Figure 3. Following HIV infection NK-cell responses to
stimulation were diminished. Natural Killer cell degranulation (A)
and IFN-c secretion (B) responses after stimulation with IL-2 alone or
with IL-2 and 721 cells (adjusted for background) or with PMA/
Ionomycin. Data are adjusted for background responses to media alone.
doi:10.1371/journal.pone.0053251.g003
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infection immune responses confound inferences about immune
responses in the early post-infection period. Secondly, most
women in this study were studied after the earliest phase of
primary HIV-1 infection, as most had either discordant or positive
serology at the time of first sampling. Thus transient events that
occur very early infection may have been missed.
Overall, we found that primary HIV-1 infection was associated
with activation of NK cells, potentially modulated by KIR
expression. We observed functional impairment of NK cells early
after HIV acquisition in the absence of anergic NK cell
expansion. Further, during primary infection NK cells acquired
the ability to home to secondary lymphoid tissues. This implies
that they may play a role in early events outside the peripheral
blood compartment. This study of matched blood specimens
obtained before HIV-1 acquisition and during the stages of
primary infection has helped delineate directionality in the
relationship between NK cells and HIV during primary HIV-1
infection.
Supporting Information
Figure S1 The gating strategy for defining NK cells that
expressed HLA-DR, a marker of activation, in matched samples
obtained pre-infection (A) or post-infection (B), included (clockwise
from top left for A and B) the gating of singlets, with forward (FSC)
and side-scatter (SSC) properties consistent with lymphocytes, that
were not monocytes (CD14neg), B-cells (CD20neg) or dead cells
(Viability dyeneg) and that were CD3 negative and expressed
CD16/CD56. Figure shows a single donor at each timepoint.
(EPS)
Figure S2 The gating strategy for defining NK cells expressing
CD107a or IFN- c and obtained pre-infection (A) or post-infection
(B) were evaluated by multiparametric flow cytometry. NK cells
were defined (shown clockwise for A and B) after gating on
singlets, lymphocytes, non monocytes (CD14neg), non B-cells
(CD20neg) or dead cells (Viability dyeneg) and that were CD3
negative but expressed CD7 (as described [18]). For each donor,
both pre-infection and post-infection responses were evaluated
following stimulation with media containing rhIL-2 alone, or with
721 cells or PMA/Ionomycin.
(EPS)
Figure S3 The frequency of NK cells (A), and the frequency of
recently divided NK cells (Ki-67pos, C) was not altered by HIV
infection (B) nor during the stages of primary HIV infection (D).
The proportion of activated NK cells was not altered during
primary infection (E).
(EPS)
Figure S4 The proportion of anergic (CD56neg), cytotoxic
(CD56dim) or cytokine-secreting (CD56hi) NK cells was not
significantly altered by HIV infection (A) nor by stage of primary
infection (B).
(EPS)
Figure 4. Early after HIV infection blood NK cells increased their expression of lymphoid, but not gut homing receptors. The
proportion of NK cells expressing CCR7 was increased following HIV infection (A). The proportion of NK cells expressing CCR7 was reduced during
later stages of primary infection (B). The proportion of NK cells that expressed a4b7, was not changed during primary HIV-1 infection (C).
doi:10.1371/journal.pone.0053251.g004
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Figure S5 The proportion of recently divided CD8+ T-cells (A),
and degranulating CD8+ T-cells (B) was increased in primary HIV
infection but the proportion of CD8pos T-cells secreting IFN-c was
not significantly altered (C).
(EPS)
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